G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. 1998

A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
Hypertension Gene Laboratory, Department of Physiology and Institute for Biomedical Research, University of Sydney, Sydney, New South Wales, Australia.

-Essential hypertensives display enhanced signal transduction through pertussis toxin-sensitive G proteins. The T allele of a C825T variant in exon 10 of the G protein beta3 subunit gene (GNB3) induces formation of a splice variant (Gbeta3-s) with enhanced activity. The T allele of GNB3 was shown recently to be associated with hypertension in unselected German patients (frequency=0.31 versus 0.25 in control). To confirm and extend this finding in a different setting, we performed an association study in Australian white hypertensives. This involved an extensively examined cohort of 110 hypertensives, each of whom were the offspring of 2 hypertensive parents, and 189 normotensives whose parents were both normotensive beyond age 50 years. Genotyping was performed by polymerase chain reaction and digestion with BseDI, which either cut (C allele) or did not cut (T allele) the 268-bp polymerase chain reaction product. T allele frequency in the hypertensive group was 0.43 compared with 0.25 in the normotensive group (chi2=22; P=0.00002; odds ratio=2.3; 95% CI=1.7 to 3.3). The T allele tracked with higher pretreatment blood pressure: diastolic=105+/-7, 109+/-16, and 128+/-28 mm Hg (mean+/-SD) for CC, CT, and TT, respectively (P=0.001 by 1-way ANOVA). Blood pressures were higher in female hypertensives with a T allele (P=0.006 for systolic and 0.0003 for diastolic by ANOVA) than they were in male hypertensives. In conclusion, the present study of a group with strong family history supports a role for a genetically determined, physiologically active splice variant of the G protein beta3 subunit gene in the causation of essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001315 Australia The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra. Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)
D017668 Age of Onset The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age-at-Onset,Age at Onset,Onset Age
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory

Related Publications

A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
November 1998, Hypertension (Dallas, Tex. : 1979),
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
April 1999, Hypertension (Dallas, Tex. : 1979),
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
January 2002, British journal of biomedical science,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
October 1999, Journal of hypertension,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
April 2000, International journal of cardiology,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
September 2000, Critical care medicine,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
June 2003, Journal of human hypertension,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
January 1998, Nature genetics,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
June 2007, Zhonghua yi xue za zhi,
A V Benjafield, and C L Jeyasingam, and D R Nyholt, and L R Griffiths, and B J Morris
January 2004, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
Copied contents to your clipboard!